1. PO-56: Low molecular weight heparin beyond 12 months in patients with cancer associated thrombosis: CAT-LONG study. Issue 213 (May 2022) Authors: Lopez-Ruz, S.; Barca-Hernando, M.; Marin-Romero, S.; Elias-Hernandez, M.T.; Otero-Candelera, R.; Jara-Palomares, L. Journal: Thrombosis research Issue: Issue 213(2022)Supplement 2 Page Start: S38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗